Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells

Growth Hormone and IGF Research

Volumn 10, Issue 6, 2000, Pages 367-377

  Salahifar, Houta ^a   Firth, Sue M ^a   Baxter, Robert C ^a   Martin, Janet L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breast cancer; DNA synthesis; IGF; IGFBP 3; Protease

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; DEGLYCOSYLATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0034491427     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2000.0180     Document Type: Article

References (34)

1. Insulin-like growth factors and their binding proteins: Biological actions
2. IGF binding proteins as modulators of IGF action
3. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol
4. Transfection of the human IGFBP-3 gene into Balb/c fibroblasts: A model for the cellular functions of IGFBPs
5. Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells
6. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease
7. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments
8. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin
9. Molecular aspects of the insulin-like growth factor binding proteins
10. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I
11. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3)
12. Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells
13. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism
14. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells
15. Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3
16. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: Inhibition by IGFs does not require IGF-IGFBP interaction
17. Differential regulation of IGFBP-3 protease activity in MCF-7 breast cancer cells by estrogen and transforming growth factor-β1
18. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum
19. Insulin-like growth factor binding protein from human plasma: Purification and characterization
20. Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3
21. Adenoviral-mediated expression of human insulin-like growth factor-binding protein-3
22. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
23. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3
24. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein
25. The role of glycosylation in the action of IGFBP-3
26. Biosensor measurement of IGF-binding to N- and C-terminal recombinant human IGFBP-3 fragments
27. Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3
28. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: An alternative mechanism in the regulation of IGF action
29. Effect of IGFBP-3 on IGF-and IGF-analog-induced IGFIR signaling
30. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain
31. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
32. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin
33. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
34. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule